NLRC4 and COVID-19: Additionally, several HLH genes associated with defective cytotoxic responses have been investigated in the context of COVID-19 [95, 96], including a 52-year-old patient carrying a GoF NLRC4 variant who had previously experienced recurrent HLH episodes [85].